Storys zum Thema Study

Schweizerischer Nationalfonds / Fonds national suisse

Shadows can damage solar panels

Bern (ots) - Shadows not only reduce the performance of photovoltaic modules integrated into buildings - they may also shorten their lifespan. "Over the next 30 years, Switzerland will need at least 20 times more solar panels to ensure its future energy supply as envisaged in the Energy Strategy 2050", according to Alessandro Virtuani, a physicist at EPFL. The majority of these panels will have to be installed on buildings, as Switzerland, like some other countries, does not ...

Globegarden Gmbh

Childcare day-to-day rethought: focus on parents / How Globegarden makes education visible

Zürich (ots) - In day-care centers, it is about the well-being of the children entrusted to them - and, increasingly, that of the parents too. With daily reports, parents' corners and educational discussions, the Swiss kindergarten provider Globegarden cares intensively for parents and allows them to participate more closely in their children's everyday lives. What is ...

Schweizerischer Nationalfonds / Fonds national suisse

The ethical dilemma of forensic therapy

Bern (ots) - Therapy and reporting to the judiciary - psychiatric professionals in prison have a conflict of loyalties. How do they deal with it? The treatment of people for whom a therapeutic measure has been ordered by the court creates a conflict of loyalties for medical professionals. A study(*) supported by the SNSF reveals how they deal with this in practice. Approximately one thousand people in Switzerland are ...

Globegarden Gmbh

Globegarden consolidates its position as a quality provider

zeb consulting

zeb Digital Mortgage Lending Study 2021 / Construction and housing financing: digital offerings required

swissstaffing - Verband der Personaldienstleister der Schweiz

More Than Equivalent: New Analysis of Wages and Overtime in Temporary Work

Helsana Gruppe

Helsana Drug Report: Spitex patients exposed to significant medication risks

Zurich (ots) - In 2019, medication costs in Switzerland totalled approximately CHF 7.6 billion. The front runners remained cancer and immune system drugs, followed by nervous system medications and metabolic preparations. The use of biosimilars (generic preparations) offers significant savings potential that unfortunately remains almost completely unexploited. In an ...

FDI World Dental Federation

Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year

Debiopharm International SA

DEBIOPHARM LAUNCHES TRILYNX - A LARGE-SCALE PHASE III CLINICAL TRIAL TO FURTHER EVALUATE XEVINAPANT IN THE TREATMENT OF HEAD & NECK CANCER

Lausanne, Switzerland (ots) - First patient dosed in the randomized, placebo-controlled Phase III study of xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) Debiopharm (www.debiopharm.com), a ...

Debiopharm International SA

DEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS

Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...

swissstaffing - Verband der Personaldienstleister der Schweiz

Flexworkers are the subject of a new study

FDI World Dental Federation

2

FDI World Dental Federation: Global survey shows that less than half (38%) of parents limit their children´s sugary food and drink intake to ensure good oral health

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - A year under fire: staff leasing sector shrinks by 4.5%

MSD Merck Sharp & Dohme AG

Swissmedic grants approval for pembrolizumab (KEYTRUDA®) in combination with axitinib (Inlyta®) for first-line therapy of advanced renal cell carcinoma(1)

Lucerne (ots) - - Swissmedic approval is based on a significant benefit in overall survival with pembrolizumab in combination with axitinib compared to sunitinib in the Phase III study KEYNOTE-426 - Pembrolizumab is the first PD-1 inhibitor that has ...

Helsana Gruppe

Helsana report shows: Medical services on the rise

Zürich (ots) - The "Volume Report" published today by Helsana elucidates the development of medical treatments. In Switzerland, increasing numbers of patients make use of medical treatments. As a result there is an increased need for coordination. General practitioners have less and less time to perform this role. The report finds great potential to meet these coordination needs in other health occupations. In its latest ...

Hochschule Luzern

Asset Management Study 2019: Sustainable investments and product specialisation as opportunities

Lucerne (ots) - The Institute of Financial Services Zug IFZ, part of Lucerne University of Applied Sciences and Arts, and the Asset Management Platform Switzerland have produced the second edition of the IFZ/AMP Asset Management Study providing a comprehensive overview on asset management in Switzerland. It shows ...

Schweizerischer Nationalfonds / Fonds national suisse

Trade agreements only partly shift environmental burden onto poorer countries

Bern (ots) - Is trade liberalisation shifting environmental burden from industrialised countries to poorer ones? This question was investigated by a research team at ETH Zurich led by Thomas Bernauer. In particular, they analysed whether, and if so how, commerce driven by free trade agreements is transferring environmental impacts from industrialised countries to ...

swissstaffing - Verband der Personaldienstleister der Schweiz

Permanent Employment for One in Two Temporary Workers

Dübendorf (ots) - Staff leasing is a controversial subject, and everyone seems to have an opinion about it. Two representative surveys conducted by gfs-zürich on behalf of swissstaffing bring new facts to the debate: one in two temporary workers seeking permanent employment were successful within 24 months of beginning their first position. In addition, ...

Hochschule Luzern

Lucerne School of Business: Who Will Survive the FinTech Evolution?

Hochschule Luzern

Hochschule Luzern: Swiss retail banks with high digitization potential

Schweizerischer Nationalfonds / Fonds national suisse

Melting glaciers have a limited impact on Swiss hydropower production

Bern (ots) - A new study quantifies the effect of glacier retreat due to global warming on hydropower production. This detailed analysis of all Swiss water resources shows that only a small percentage is provided by glacier meltwater. Consequently, the reduction of these waters predicted for the end of the 21st century poses no threat to Swiss hydropower production. ...

Schweizerischer Nationalfonds / Fonds national suisse

Eating less is healthy thanks to gut bacteria

Bern (ots) - Mice with a lower calorie intake live longer and are both healthier and leaner. A team of researchers funded by the SNSF may have found the reason for this positive effect: much of it is down to gut microbial communities and how they affect the immune system. The researchers also found compounds that mimic caloric restriction and may transform obesity treatments. Reducing the intake of calories by up to 40% ...

Sequana Medical AG

Sequana Medical announces inclusion of alfapump® in EASL Clinical Practice Guidelines and presentation of study demonstrating physical component of QOL is predictor of mortality in refractory ascites

Zurich (ots) - Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease & malignant ascites, announces two important developments at the recent EASL (European Association for the Study of the Liver) International Liver Congress 2018. First, ...

Sequana Medical AG

Sequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study

Zurich, SWITZERLAND (ots) - Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of ...